Article
Genetic mutation analysis at early stages of cell line development using next generation sequencing.
Biotechnology progress - 1 May 2016
Wright Chapman, Groot Joost, Swahn Samantha, McLaughlin Helen, Liu Mei, Xu Chongfeng, Sun Chao, Zheng Eric, Estes Scott
Abstract excerpt
A central goal for most biopharmaceutical companies is to reduce the development timeline to reach clinical proof of concept. This objective requires the development of tools that ensure the quality of biotherapeutic material destined for the clinic. Recent advances in high throughput protein analytics provide confidence in our ability to assess productivity and product quality attributes at early stages of cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
